Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

Please Note: The journal is closed for new submissions until 1st Sept 2026 (to catch up with record numbers in recent months).

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

NB:

  • The journal does not accept case reports
  • From 6 April 2026 APCs will apply to manuscripts submitted from countries classified as upper-middle-income or high-income.
  • Manuscripts may be declined after 60 days if suitable reviewers cannot be secured, to minimise delays and allow authors to submit their work elsewhere.
Articles
Editorials
Special issues
Author interviews
770-highlights-from-the-win-2017-symposium-26-27-june-2017-paris-france-expediting-global-innovation-in-precision-cancer-medicine
Will Davies
721-dual-role-of-inflammatory-mediators-in-cancer
TG Shrihari
703-biomarkers-come-of-age-pd1-in-the-frontline-and-cell-cycle-therapy-swells-the-ranks-of-personalised-therapy-in-the-european-society-of-medical-oncology-esmo-congress-copenhagen-7-10-october-2016
Will Davies
691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation
Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada
676-conditional-survival-of-metastatic-renal-cell-carcinoma-patients-treated-with-high-dose-interleukin-2
David M Gill, David D Stenehjem, Kinjal Parikh, Joseph Merriman, Arun Sendilnathan, Archana M Agarwal, Andrew W Hahn, Sumati Gupta, Srinivas Kiran Tantravahi, Wolfram E Samlowski, Neeraj Agarwal
669-highlights-from-the-2016-win-symposium-27-29-june-2016-paris-personalised-therapy-beyond-next-generation-sequencing
Richard Schilsky, Will Davies
660-role-of-nanotechnology-and-gene-delivery-systems-in-trail-based-therapies
George E Naoum, Fady Tawadros, Ammad Ahmad Farooqi, Muhammad Zahid Qureshi, Sobia Tabassum, Waleed Arafat, Donald J Buchsbaum
649-cancer-associated-thrombotic-microangiopathy
K Govind Babu, Gita R Bhat
646-squamous-cell-carcinoma-of-the-rectum-a-consequence-of-immunosuppression-resulting-from-inhibiting-tumour-necrosis-factor-tnf
Alexandra Silverton, Roy A Raad, Leah Katz, Andrea Downey, Franco M Muggia
627-diagnostic-and-therapeutic-update-of-mantle-cell-lymphoma-mcl-analysis-of-seven-cases-treated-in-a-centre-in-one-year
Carmen Herrero-Vicent, Isidro Machado, Carmen Illueca, Amparo Avaria, Claudia Salazar, Abraham Hernandez, Sergio Sandiego, Javier Lavernia

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation